Hyun Soo Ko (Hyun S Ko)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Computed Tomography

Advanced Non Small Cell Lung Cancer

Radical Prostatectomy

Lymph Node Metastasis

Top Venues

European radiology

ANZ journal of surgery

Journal of cachexia, sarcopenia and muscle

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Tran, Daniel Ginzburg, Wei Hong, Ulrike Attenberger, Hyun Soo Ko
Post-radiotherapy stage III/IV non-small cell lung cancer radiomics research: a systematic review and comparison of CLEAR and RQS frameworks. European radiology (2024)
Kevin Tran, Daniel Ginzburg, Wei Hong, Ulrike Attenberger, Hyun Soo Ko
Post-radiotherapy stage III/IV non-small cell lung cancer radiomics research: a systematic review and comparison of CLEAR and RQS frameworks. European radiology (2024)
Hyun Soo Ko, Linda Denehy, Lara Edbrooke, Shadi Albarqouni, Ulrike Attenberger, Benjamin L Parker, Andrew Cox, Brian Le, Louise Cheng
Enhancing oncological care: A guide to setting up a new multidisciplinary cancer cachexia clinic within a tertiary centre. Journal of cachexia, sarcopenia and muscle (2023)
James Alex Malcolm, Mark Tacey, Peter Gibbs, Belinda Lee, Hyun Soo Ko
Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings. European radiology (2023)
Hyun Soo Ko
Correction to: Advancing radiomics research translation through a public database. European radiology (2023)
Hyun Soo Ko
Advancing radiomics research translation through a public database. European radiology (2023)
Alexander Grogan, Benjamin Loveday, Michael Michael, Hui-Li Wong, Peter Gibbs, Benjamin Thomson, Belinda Lee, Hyun Soo Ko
Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma. ANZ journal of surgery 92 (7-8) (2022)
Kenji M Fujihara, Mariana Corrales Benitez, Carlos S Cabalag, Bonnie Z Zhang, Hyun Soo Ko, David S Liu, Kaylene J Simpson, Ygal Haupt, Lara Lipton, Sue Haupt, Wayne A Phillips, Nicholas James Clemons
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status. Molecular cancer therapeutics 20 (10) (2021)